Director, Neuro-Oncology (Associate Professor)
Rutgers Cancer Institute of New Jersey seeks applications for the position of Director of Neuro-Oncology. The Director will have the exciting opportunity to lead a multidisciplinary clinical program within an NCI designated Comprehensive Cancer Center and the academic hub of the RWJ Barnabas Health System oncology service for the state of New Jersey. Academic appointment will be in the Department of Medicine, Rutgers Robert Wood Johnson Medical School. Academic rank commensurate with experience. Competitive recruitment package exists.
Applicants should submit a CV, a research statement, a cover letter detailing how the candidate’s work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information or upload reference letters. Please contact cinjcareers@cinj.rutgers.edu with any questions about the application process.
Minimum Qualifications
MD/DO
Board Certification- ABIM or Neurology
3-year fellowship training
Active/eligible for a NJ Medical License.
Position Information
Department: CINJ Medical - Solid Tumor
Salary: Commensurate With Experience
Special Instructions to Applicants
Applicants should submit a CV, a research statement, a cover letter detailing how the candidate’s work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information or upload reference letters. Please contact cinjcareers@cinj.rutgers.edu with any questions about the application process.
Overview
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy, and cardio-oncology.
#J-18808-Ljbffr
